Percutaneous Endoscopic Decompression for Lumbar Canal Stenosis
1 other identifier
interventional
600
1 country
1
Brief Summary
Lumbar spinal stenosis (LSS) is the most common spinal degenerative disease. For conservative treatment failure, open lumbar decompression and fusion surgery is the main surgical treatment. After decades of development, open lumbar decompression and fusion surgery has been the standard treatment. However, there are still people and conditions that cannot be covered, such as elderly people who intolerable surgery, severe osteoporosis, and re-stenosis at adjacent segments after fusion. Percutaneous spinal endoscopic lumbar spinal decompression technique could be performed under local anesthesia, soft tissue damage is minimized, and effective spinal decompression can be achieved. There are still some controversial points of LSS decompression under percutaneous endoscope surgery, such as the range of decompression, choice of approach, postoperative spinal stability, learning curve, surgical safety, long-term effects of endoscopic treatment of restenosis at adjacent segments after fusion surgery. The purpose of this study was to solve these controversial points. A multi-center, prospective registration study based on the real world is planned. The total sample size is about 600 cases (300 cases in endoscopic surgery group, 300 cases in open decompression and fusion group). The mid- to long-term clinical efficacy and safety were evaluated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 15, 2020
CompletedStudy Start
First participant enrolled
February 1, 2020
CompletedFirst Posted
Study publicly available on registry
February 5, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedFebruary 5, 2020
January 1, 2020
1.9 years
January 15, 2020
January 31, 2020
Conditions
Outcome Measures
Primary Outcomes (3)
Modified MacNab criteria
1 years after surgery
Visual Analog Scale (VAS)
VAS of leg and back
at 1 years after surgery
Oswestry Disability Index(ODI)
at 1 years after surgery
Secondary Outcomes (2)
Range of motion(ROM)
at 1 years after surgery
Adjacent Segment Disease
at 1 years after surgery
Study Arms (2)
Percutaneous endoscopic surgery group
OTHEROpen decompression and fusion surgery group
OTHERInterventions
One group treated by percutaneous endoscopic surgery. The another group treated by open decompression and fusion surgery
Eligibility Criteria
You may qualify if:
- Patients with symptomatic lumbar canal stenosis(including central canal, lateral recess, foraminal and extraforaminal) despite more than 6 weeks of conservative treatment; Pathology was confirmed by both computed tomography and magnetic resonance imaging The operative level≤2
You may not qualify if:
- Segmental instability Simple disc herniation Coexisting pathological conditions, such as tumor and infection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Peking University Third Hospitallead
- Beijing Shijitan Hospital, Capital Medical Universitycollaborator
- Xuanwu Hospital, Beijingcollaborator
- Beijing Changping Hospitalcollaborator
Study Sites (1)
Peking University Third Hospital
Beijing, Beijing Municipality, 100000, China
Related Publications (1)
Zhai S, Zhao W, Zhu B, Huang X, Liang C, Hai B, Ding L, Zhu H, Wang X, Wei F, Chu H, Liu X. The effectiveness of percutaneous endoscopic decompression compared with open decompression and fusion for lumbar spinal stenosis: protocol for a multicenter, prospective, cohort study. BMC Musculoskelet Disord. 2022 May 27;23(1):502. doi: 10.1186/s12891-022-05440-4.
PMID: 35624443DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Xiaoguang Liu, M.D.,Ph.D.
Peking University Third Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PH.D.,M.D.,Professor
Study Record Dates
First Submitted
January 15, 2020
First Posted
February 5, 2020
Study Start
February 1, 2020
Primary Completion
December 31, 2021
Study Completion
December 31, 2023
Last Updated
February 5, 2020
Record last verified: 2020-01
Data Sharing
- IPD Sharing
- Will not share